Drug
Atazanavir/ritonavir clinical trials
- studies test it
- 12
- open now
- 0
- in phase 3
- 1
- first study started
- 2002
How studies write it
Studies that test it under each name
Name
Development codes
Combined with it in one product
Studies by the year they started
12 studies that test it; most in 2006 (4)
| Year | Studies |
|---|---|
| 2002 | 1 |
| 2004 | 1 |
| 2005 | 1 |
| 2006 | 4 |
| 2007 | 2 |
| 2010 | 1 |
| 2014 | 1 |
| 2020 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 2
- Phase 2
- 1
- Phase 3
- 1
- Phase 4
- 6
- No phase
- 2
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 3 · Other 9
Bristol-Myers Squibb (3) · Obafemi Awolowo University (1) · Germans Trias i Pujol Hospital (1) · Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections (1) · Imperial College London (1) · Juan A. Arnaiz (1) · Göteborg University (1) · International Antiviral Therapy Evaluation Center (1)
Often tested with
Tested in the same studies.
Efavirenz (4) · Ritonavir (4) · Atazanavir (4) · Nevirapine (2) · Saquinavir (2) · Lopinavir-ritonavir drug combination (2) · Tenofovir (2) · Nitazoxanide (1)
Studies
Open first, then newest update. How each study uses Atazanavir/ritonavir is read from its arms, and is right about nine times in ten.
Testing it · 12
- Pharmacokinetic Interaction Between Nitazoxanide and Atazanavir/Ritonavir in Healthy VolunteersCompletedNot applicableObafemi Awolowo UniversityNCT05680792Written as Atazanavir/ritonavir
- Study to Determine the Pharmacokinetic Behavior of Antiretroviral Drugs in Patients Infected by HIVCompletedPhase 1Germans Trias i Pujol HospitalNCT00307502Written as Atazanavir/ritonavir
- Evaluating Pharmacokinetic Interactions With Vaginal Ring Contraceptives and ARTCompletedPhase 2Advancing Clinical Therapeutics Globally for HIV/AIDS and Other InfectionsNCT01903031Written as ATV/r
- Switching From Efavirenz to Atazanavir/ Ritonavir in HIV-infected Subjects With Good Virologic SuppressionTerminatedPhase 4The Cleveland ClinicNCT01194856Written as Atazanavir/ritonavir
- Roll-Over Protocol To Provide Atv And/Or Truvada For Extended AccessCompletedPhase 3Bristol-Myers SquibbNCT01003990Written as Atazanavir/Ritonavir
- The CogNaive Study: Assessing Changes in Neurocognitive Function in Treatment Naïve HIV-1 Positive SubjectsCompletedPhase 4Imperial College LondonNCT00540137Written as atazanavir/ritonavir
- Once-daily Antiretroviral Therapy in HIV-1 Infected Patients With CD4+ Cell Counts Below 100 Cells/MclCompletedPhase 4Juan A. ArnaizNCT00532168Written as tenofovir + emtricitabine + atazanavir-ritonavir
- A Study on Antiretroviral Therapy (ART) Naïve Patients On Different Regimens to Treat Hiv (NORTHIV)CompletedPhase 4Göteborg UniversityNCT01445223Written as Atazanavir ritonavir
- Drug Interaction Study With Proton Pump InhibitorCompletedPhase 1Bristol-Myers SquibbNCT00357240Written as Atazanavir/Ritonavir
- BASIC: Boosted Atazanavir or Saquinavir Induced Lipid ChangesCompletedPhase 4International Antiviral Therapy Evaluation CenterNCT00389402Written as atazanavir/ritonavir
- Metabolic Effects of Switching Kaletra to Boosted ReyatazCompletedNot applicableMassachusetts General HospitalNCT00413153Written as atazanavir/ritonavir
- Drug Interaction Study of Famotidine and Atazanavir With Ritonavir in HIV-Infected PatientsCompletedPhase 4Bristol-Myers SquibbNCT00384904Written as Atazanavir/Ritonavir
As the comparator · 3 — what is tested is compared with Atazanavir/ritonavir
- Switch to Unboosted Atazanavir With Tenofovir StudyCompletedPhase 4University of British ColumbiaNCT01351740Written as atazanavir/ritonavir
- Safety Study of Raltegravir in HIV/HCV Co-infected PatientsWithdrawnPhase 4University Hospital, BonnNCT01225705Written as Atazanavir/ritonavir
- Safety and Efficacy Study Comparing Raltegravir to a Protease Inhibitor in Treatment-naïve, HIV/Hepatitis C Drug UsersStatus unknownPhase 4St. James's Hospital, IrelandNCT01105611Written as Atazanavir/Ritonavir